0001891257-22-000002.txt : 20220112 0001891257-22-000002.hdr.sgml : 20220112 20220112162023 ACCESSION NUMBER: 0001891257-22-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220110 FILED AS OF DATE: 20220112 DATE AS OF CHANGE: 20220112 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Girolamo Todd C CENTRAL INDEX KEY: 0001891257 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33650 FILM NUMBER: 22526779 MAIL ADDRESS: STREET 1: 110 ALLEN ROAD STREET 2: 2ND FLOOR CITY: BASKING RIDGE STATE: NJ ZIP: 07920 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CALADRIUS BIOSCIENCES, INC. CENTRAL INDEX KEY: 0000320017 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 222343568 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 110 ALLEN ROAD STREET 2: SECOND FLOOR CITY: BASKING RIDGE STATE: NJ ZIP: 07920 BUSINESS PHONE: 908-229-2590 MAIL ADDRESS: STREET 1: 110 ALLEN ROAD STREET 2: SECOND FLOOR CITY: BASKING RIDGE STATE: NJ ZIP: 07920 FORMER COMPANY: FORMER CONFORMED NAME: Caladrius Biosciences, Inc. DATE OF NAME CHANGE: 20150608 FORMER COMPANY: FORMER CONFORMED NAME: NeoStem, Inc. DATE OF NAME CHANGE: 20060906 FORMER COMPANY: FORMER CONFORMED NAME: PHASE III MEDICAL INC/DE DATE OF NAME CHANGE: 20030819 4 1 wf-form4_164202240462407.xml FORM 4 X0306 4 2022-01-10 0 0000320017 CALADRIUS BIOSCIENCES, INC. CLBS 0001891257 Girolamo Todd C C/O CALADRIUS BIOSCIENCES, INC. 110 ALLEN ROAD, 2ND FLOOR BASKING RIDGE NJ 07920 0 1 0 0 CLO, SVP of Corp Dev Common Stock 2022-01-10 4 A 0 129000 0 A 187675 D Common Stock 2022-01-10 4 F 0 17405 0.917 D 170270 D Common Stock 2022-01-11 4 F 0 4722 0.8651 D 165548 D Stock Option (Right to Buy) 0.917 2022-01-10 4 A 0 65000 0 A 2022-01-10 2032-01-10 Common Stock 65000.0 65000 D Represents 129,000 restricted stock awards granted under the Issuer's 2018 Equity Incentive Compensation Plan. The restricted stock awards vest in four equal installments, with one-fourth of the shares vesting on the date of grant and an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date. Includes 136,500 unvested restricted stock. Shares withheld as payment of a tax liability on vesting of restricted stock. Includes 127,750 unvested restricted stock. One-fourth of the shares underlying the stock options vest immediately on the grant date, with an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date. Todd C. Girolamo 2022-01-12